In addition, AML patients carrying missense driver mutations of FLT3 (i.e., TKD) and genetic rearrangements of CBFB and KMT2A (ex-MLL) also exhibited the ATP1A1/BCL2L1high phenotype (Supplementary Fig. S4). This evidence concerns the gene ATP1A1 and acute myeloid leukemia.